Clobazam
Showing 1 - 25 of 36
Epilepsy Trial in Spain, United Kingdom (GWP42003-P 20 mg/kg/Day Dose, Placebo, Clobazam)
Completed
- Epilepsy
- GWP42003-P 20 mg/kg/Day Dose
- +2 more
-
Barcelona, Spain
- +5 more
Sep 22, 2022
Drug Resistant Epilepsy Trial in Jakarta Pusat, Jakarta (Valproic acid, Carbamazepin, Phenytoin)
Recruiting
- Drug Resistant Epilepsy
- Valproic acid
- +5 more
-
Jakarta Pusat, Jakarta, Indonesia
- +2 more
Jan 14, 2023
Epilepsy, Anxiety Trial in Baltimore (Clobazam)
Completed
- Epilepsy
- Anxiety
- Clobazam
-
Baltimore, MarylandKennedy Krieger Institute
Feb 13, 2021
Electrical Status Epilepticus of Slow-Wave Sleep Trial in Lake Success (Epidiolex 100 mg/mL Oral Solution, Placebo)
Recruiting
- Electrical Status Epilepticus of Slow-Wave Sleep
- Epidiolex 100 mg/mL Oral Solution
- Placebo
-
Lake Success, New YorkNorthwell Health
Apr 5, 2022
Epileptic Encephalopathy Trial in Canada (CanniMed® 1:20)
Active, not recruiting
- Epileptic Encephalopathy
- CanniMed® 1:20
-
Vancouver, British Columbia, Canada
- +3 more
Sep 27, 2021
Seizures Associated With EMAS Trial (GWP42003-P, Placebo)
Recruiting
- Seizures Associated With EMAS
- GWP42003-P
- Placebo
-
Birmingham, Alabama
- +5 more
Jan 30, 2023
Benzodiazepin Withdrawn After Curative Epilepsy Surgery in Focal
Terminated
- Cognitive Impact of Antiepileptic Drugs
-
Paris, Ile De France, FranceCHU Robert-Debré
Mar 23, 2021
Refractory Status Epilepticus Trial in Detroit (Perampanel)
Not yet recruiting
- Refractory Status Epilepticus
-
Detroit, MichiganWayne State University
Jan 6, 2023
Epilepsia Partialis Continua, Kojewnikov's Epilepsy, Epilepsy Trial in Camden (Clobazam, Clonazepam, Lorazepam)
Terminated
- Epilepsia Partialis Continua
- +2 more
- Clobazam
- +2 more
-
Camden, New JerseyCooper Universtiy Hospital
May 3, 2018
Resistant Epilepsy, Drug, Adolescent Epilepsy, Children Epilepsy Trial in Petach Tikvah, Ljubljana (MGCND00EP1, Placebo, ECG)
Not yet recruiting
- Resistant Epilepsy, Drug
- +3 more
- MGCND00EP1
- +4 more
-
Petach Tikvah, Central District, Israel
- +1 more
Aug 23, 2022
Photosensitive Epilepsy Trial in Boston (Fenfluramine Hydrochloride)
Active, not recruiting
- Photosensitive Epilepsy
- Fenfluramine Hydrochloride
-
Boston, MassachusettsMassachusetts General Hospital
Sep 16, 2022
Epilepsy Trial in University (cannabidiol extract)
Unknown status
- Epilepsy
- cannabidiol extract
-
University, MississippiUniversity of Mississippi
Oct 14, 2020
Epilepsy Trial run by the (Clobazam)
Unknown status
- Epilepsy
- Clobazam
-
Bethesda, MarylandMidAtlantic Epilepsy and Sleep Center
Mar 22, 2017
Refractory Epilepsy Trial in Phoenix (clobazam (Onfi), Initial conversion and titration, Conversion schedule - Week 1)
Unknown status
- Refractory Epilepsy
- clobazam (Onfi)
- +4 more
-
Phoenix, ArizonaBanner Health
Mar 1, 2017
Neuropathic Pain Trial in Geneva (NDMC 20mg, NDMC60mg, Clonazepam 1.5mg)
Completed
- Neuropathic Pain
- NDMC 20mg
- +3 more
-
Geneva, SwitzerlandUGeneva
Apr 18, 2019
Epilepsy, Dravet Syndrome Trial in United Kingdom, United States (GWP42003-P 5 mg/kg/day Dose, Placebo control, GWP42003-P 10
Completed
- Epilepsy
- Dravet Syndrome
- GWP42003-P 5 mg/kg/day Dose
- +3 more
-
Miami, Florida
- +10 more
Jul 26, 2018
Epilepsy Trial in United Kingdom (Ketogenic diet, Antiepileptic drug therapy)
Unknown status
- Epilepsy
- Ketogenic diet
- Antiepileptic drug therapy
-
Birmingham, United Kingdom
- +10 more
May 2, 2017
Epilepsy Trial run by the (perampanel)
Terminated
- Epilepsy
-
Bethesda, MarylandMidAtlantic Epilepsy and Sleep Center
Aug 28, 2017